查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球医院感染控制市场 - 全球产业分析、规模、份额、成长、趋势、预测 (2031) - 按产品、按最终用户、按地区
市场调查报告书
商品编码
1398752

全球医院感染控制市场 - 全球产业分析、规模、份额、成长、趋势、预测 (2031) - 按产品、按最终用户、按地区

Hospital Acquired Infection Control Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:
出版日期: | 出版商: Fairfield Market Research | 英文 201 Pages | 商品交期: 2-5个工作天内

价格
简介目录

全球医院感染控制市场经历了显着成长，预计2024年全球销售额将达到68亿美元，到2031年底将达到96亿美元。

过去十年，由于先进医疗技术的引入，医疗保健环境发生了重大变化。 随着传染病和慢性病的盛行率迅速增加，消毒灭菌设备的需求空前巨大。

大众对医疗保健相关感染的认识不断提高，对感染控制措施的需求也越来越大。 旨在加强医疗机构感染控制系统的政府计划在市场扩张中发挥至关重要的作用。 传染病的日益普及正在推动对感染控制技术的需求。 此次疫情凸显了医疗环境中感染控制的重要性，导致相关设备的需求增加。

本报告调查了全球医院感染控制市场，并概述了市场概况、按产品、最终用户、地区划分的趋势以及进入市场的公司的竞争趋势。

目录

第 1 章执行摘要

第二章市场概述

  • 市场定义与细分
  • 市场动态
  • 价值链分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影响分析
  • 乌克兰和俄罗斯之间衝突的影响
  • 经济概况
  • 杵分析

第 3 章 2018-2031 年全球医院感染控制市场展望

  • 2018-2031 年全球医院感染控制市场前景，依产品、价值（十亿美元）、数量（百万单位）
  • 2018-2031 年全球医院感染控制市场前景（按最终用户划分）、价值（十亿美元）、数量（百万单位）
  • 2018-2031 年全球医院感染控制市场前景（按地区、价值（十亿美元）、数量（百万台））

第 4 章 2018-2031 年北美医院感染控制市场展望

第五章欧洲医院感染控制市场展望，2018-2031

第 6 章亚太地区医院感染控制市场展望，2018-2031

第 7 章拉丁美洲医院感染控制市场前景，2018-2031

第 8 章 2018-2031 年中东和非洲医院感染控制市场展望

第九章竞争态势

  • 产品和最终用户热图
  • 製造商和最终用户的热图
  • 2023 年公司市占率分析
  • 竞争对手仪表板
  • 公司简介
    • Olympus Corporation
    • Medivators Inc. (Cantel Medical Corp.)
    • Getinge Group
    • STERIS Plc.
    • Belimed AG (Metall Zug)
    • Steelco S.P.A.
    • Pfizer Inc.,
    • F. Hoffmann-La Roche Ltd,
    • Merck & Co.,
    • Advanced Sterilization Products Services Inc.
    • Abbott Laboratories
    • Bayer AG
    • The 3M Company
    • Cepheid Inc.
    • UVision360 Inc.

第 10 章附录

简介目录

The Hospital Acquired Infection Control Market is poised for substantial growth, with worldwide revenue reaching US$ 6.8 Billion in 2024 and anticipated to propel the market to US$ 9.6 Billion by the end of 2031, according to the latest report by Fairfield Market Research.

Changing Healthcare Infrastructure and the Demand for Infection Control

Over the past decade, the healthcare landscape has undergone significant transformations, marked by the adoption of advanced medical technologies. As the prevalence of infectious and chronic diseases has surged, the need for disinfection and sterilization equipment has never been more critical.

Driving Factors for Hospital Acquired Infection Control Market Expansion

Several factors are contributing to the growing demand for hospital-acquired infection control technology:

  • Rising Public Awareness: Increasing awareness about healthcare-associated infections among the public is driving the need for infection control measures.
  • Government Initiatives: Government programs aimed at strengthening infection control systems in medical facilities are playing a pivotal role in market expansion.
  • Prevalence of Infectious Diseases: The rising incidence of infectious and communicable diseases is fueling the demand for infection control technology.
  • Impact of COVID-19: The pandemic underscored the importance of infection control in healthcare settings, leading to increased demand for related equipment.

Manufacturers Expanding Their Markets

Manufacturers in the hospital acquired infection control market are expanding their reach through various strategies:

  • Increased awareness about personal hygiene is driving the demand for sterilized medical equipment, especially as the number of surgical procedures rises.
  • The demand for nosocomial infection control equipment is growing as people recognize the benefits of sterilization.
  • Minimally invasive procedures and the rise of outpatient services are contributing to market growth.
  • Increasing government initiatives and growing public awareness are expanding the number of outpatients, further driving market progress.

Challenges in Market Progress

While the hospital acquired infection control market holds immense potential, challenges exist:

  • The complexity of infection control methods and the need for advanced technologies can be obstacles.
  • Reprocessing technology for medical devices poses challenges in ensuring their safety for reuse, affecting market expansion to some extent.

Booming Market in the United States

The United States presents a highly lucrative market for hospital-acquired infection control equipment due to its advanced healthcare system, high healthcare costs, and widespread public awareness of infection control issues. It is expected to generate a significant share of the region's revenue.

Emerging Market in China

China is emerging as a prominent market for hospital-acquired infection control, driven by increasing public awareness of hospital-acquired infections, government support programs, and a rising number of such infections. China is expected to dominate in terms of revenue share.

Focus on India

India, as the second-most populous country in the world, offers substantial potential for hospital-acquired infection control equipment suppliers. As hygiene awareness and attention to healthcare intensify, India is likely to experience significant growth in demand for disinfection equipment. The nation's healthcare infrastructure is expected to advance rapidly over the next decade, presenting opportunities for local market players.

Competitive Landscape

The healthcare-associated infections segment has gained significant attention, prompting key industry players to invest in research and development and launch new products. Some key companies profiled in the hospital acquired infection control market include Olympus Corporation, Medivators Inc. (Cantel Medical Corp.), Getinge Group, STERIS Plc., Belimed AG (Metall Zug), Steelco S.P.A, Pfizer Inc., F. Hoffmann-La Roche Ltd, Merck & Co., Advanced Sterilization Products Services Inc. (Johnson & Johnson), Abbott Laboratories, Bayer AG, Alere Inc., The 3M Company, Cepheid Inc., and UVision360 Inc.

Market Segmentation

By Product :

  • Heat Sterilization Equipment
    • Moist Heat Sterilization Equipment
    • Dry Heat Sterilization Equipment
  • Low-Temperature Sterilization Equipment
  • Radiation Sterilization Equipment
  • Disinfection Equipment
  • Disinfector
    • Washer Disinfector
    • Flusher Disinfector
  • Endoscopic Reprocessor Systems
    • Single Basin Endoscopic Reprocessor Systems
    • Dual Basin Endoscopic Reprocessor Systems
  • Disinfectants

By End User :

  • Hospitals
  • Ambulatory Surgical Centres
  • Medical Institutions
  • Diagnostic Laboratories
  • Clinics

By Region :

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Hospital Acquired Infection Control Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Hospital Acquired Infection Control Market Outlook, 2018 - 2031

  • 3.1. Global Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Heat Sterilization Equipment
        • 3.1.1.1.1. Moist Heat Sterilization Equipment
        • 3.1.1.1.2. Dry Heat Sterilization Equipment
      • 3.1.1.2. Low-Temperature Sterilization Equipment
      • 3.1.1.3. Radiation Sterilization Equipment
      • 3.1.1.4. Disinfection Equipment
        • 3.1.1.4.1. Disinfector
          • 3.1.1.4.1.1. Disinfector
            • 3.1.1.4.1.1.1. Washer Disinfector
            • 3.1.1.4.1.1.2. Flusher Disinfector
        • 3.1.1.4.2. Flusher Disinfector
      • 3.1.1.5. Endoscopic Reprocessor Systems
        • 3.1.1.5.1. Single Basin Endoscopic Reprocessor Systems
        • 3.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems
      • 3.1.1.6. Disinfectants
  • 3.2. Global Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Hospitals
      • 3.2.1.2. Ambulatory Surgical Centres
      • 3.2.1.3. Medical Institutions
      • 3.2.1.4. Diagnostic Laboratories
      • 3.2.1.5. Clinics
  • 3.3. Global Hospital Acquired Infection Control Market Outlook, by Region, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. North America
      • 3.3.1.2. Europe
      • 3.3.1.3. Asia Pacific
      • 3.3.1.4. Latin America
      • 3.3.1.5. Middle East & Africa

4. North America Hospital Acquired Infection Control Market Outlook, 2018 - 2031

  • 4.1. North America Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Heat Sterilization Equipment
        • 4.1.1.1.1. Moist Heat Sterilization Equipment
        • 4.1.1.1.2. Dry Heat Sterilization Equipment
      • 4.1.1.2. Low-Temperature Sterilization Equipment
      • 4.1.1.3. Radiation Sterilization Equipment
      • 4.1.1.4. Disinfection Equipment
        • 4.1.1.4.1. Disinfector
          • 4.1.1.4.1.1. Disinfector
            • 4.1.1.4.1.1.1. Washer Disinfector
            • 4.1.1.4.1.1.2. Flusher Disinfector
        • 4.1.1.4.2. Flusher Disinfector
      • 4.1.1.5. Endoscopic Reprocessor Systems
        • 4.1.1.5.1. Single Basin Endoscopic Reprocessor Systems
        • 4.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems
      • 4.1.1.6. Disinfectants
  • 4.2. North America Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Hospitals
      • 4.2.1.2. Ambulatory Surgical Centres
      • 4.2.1.3. Medical Institutions
      • 4.2.1.4. Diagnostic Laboratories
      • 4.2.1.5. Clinics
  • 4.3. North America Hospital Acquired Infection Control Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. U.S. Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 4.3.1.2. U.S. Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 4.3.1.3. Canada Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 4.3.1.4. Canada Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Hospital Acquired Infection Control Market Outlook, 2018 - 2031

  • 5.1. Europe Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Heat Sterilization Equipment
        • 5.1.1.1.1. Moist Heat Sterilization Equipment
        • 5.1.1.1.2. Dry Heat Sterilization Equipment
      • 5.1.1.2. Low-Temperature Sterilization Equipment
      • 5.1.1.3. Radiation Sterilization Equipment
      • 5.1.1.4. Disinfection Equipment
        • 5.1.1.4.1. Disinfector
          • 5.1.1.4.1.1. Disinfector
            • 5.1.1.4.1.1.1. Washer Disinfector
            • 5.1.1.4.1.1.2. Flusher Disinfector
        • 5.1.1.4.2. Flusher Disinfector
      • 5.1.1.5. Endoscopic Reprocessor Systems
        • 5.1.1.5.1. Single Basin Endoscopic Reprocessor Systems
        • 5.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems
      • 5.1.1.6. Disinfectants
  • 5.2. Europe Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Hospitals
      • 5.2.1.2. Ambulatory Surgical Centres
      • 5.2.1.3. Medical Institutions
      • 5.2.1.4. Diagnostic Laboratories
      • 5.2.1.5. Clinics
  • 5.3. Europe Hospital Acquired Infection Control Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Germany Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.2. Germany Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.3. U.K. Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.4. U.K. Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.5. France Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.6. France Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.7. Italy Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.8. Italy Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.9. Turkey Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.10. Turkey Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.11. Russia Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.12. Russia Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.13. Rest of Europe Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 5.3.1.14. Rest of Europe Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Hospital Acquired Infection Control Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Heat Sterilization Equipment
        • 6.1.1.1.1. Moist Heat Sterilization Equipment
        • 6.1.1.1.2. Dry Heat Sterilization Equipment
      • 6.1.1.2. Low-Temperature Sterilization Equipment
      • 6.1.1.3. Radiation Sterilization Equipment
      • 6.1.1.4. Disinfection Equipment
        • 6.1.1.4.1. Disinfector
          • 6.1.1.4.1.1. Disinfector
            • 6.1.1.4.1.1.1. Washer Disinfector
            • 6.1.1.4.1.1.2. Flusher Disinfector
        • 6.1.1.4.2. Flusher Disinfector
      • 6.1.1.5. Endoscopic Reprocessor Systems
        • 6.1.1.5.1. Single Basin Endoscopic Reprocessor Systems
        • 6.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems
      • 6.1.1.6. Disinfectants
  • 6.2. Asia Pacific Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Hospitals
      • 6.2.1.2. Ambulatory Surgical Centres
      • 6.2.1.3. Medical Institutions
      • 6.2.1.4. Diagnostic Laboratories
      • 6.2.1.5. Clinics
  • 6.3. Asia Pacific Hospital Acquired Infection Control Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. China Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.2. China Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.3. Japan Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.4. Japan Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.5. South Korea Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.6. South Korea Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.7. India Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.8. India Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.9. Southeast Asia Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.10. Southeast Asia Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.11. Rest of Asia Pacific Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 6.3.1.12. Rest of Asia Pacific Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Hospital Acquired Infection Control Market Outlook, 2018 - 2031

  • 7.1. Latin America Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Heat Sterilization Equipment
        • 7.1.1.1.1. Moist Heat Sterilization Equipment
        • 7.1.1.1.2. Dry Heat Sterilization Equipment
      • 7.1.1.2. Low-Temperature Sterilization Equipment
      • 7.1.1.3. Radiation Sterilization Equipment
      • 7.1.1.4. Disinfection Equipment
        • 7.1.1.4.1. Disinfector
          • 7.1.1.4.1.1. Disinfector
            • 7.1.1.4.1.1.1. Washer Disinfector
            • 7.1.1.4.1.1.2. Flusher Disinfector
        • 7.1.1.4.2. Flusher Disinfector
      • 7.1.1.5. Endoscopic Reprocessor Systems
        • 7.1.1.5.1. Single Basin Endoscopic Reprocessor Systems
        • 7.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems
      • 7.1.1.6. Disinfectants
  • 7.2. Latin America Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 7.2.1. Key Highlights
      • 7.2.1.1. Hospitals
      • 7.2.1.2. Ambulatory Surgical Centres
      • 7.2.1.3. Medical Institutions
      • 7.2.1.4. Diagnostic Laboratories
      • 7.2.1.5. Clinics
  • 7.3. Latin America Hospital Acquired Infection Control Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Brazil Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.3.1.2. Brazil Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.3.1.3. Mexico Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.3.1.4. Mexico Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.3.1.5. Argentina Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.3.1.6. Argentina Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.3.1.7. Rest of Latin America Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 7.3.1.8. Rest of Latin America Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Hospital Acquired Infection Control Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Hospital Acquired Infection Control Market Outlook, by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Heat Sterilization Equipment
        • 8.1.1.1.1. Moist Heat Sterilization Equipment
        • 8.1.1.1.2. Dry Heat Sterilization Equipment
      • 8.1.1.2. Low-Temperature Sterilization Equipment
      • 8.1.1.3. Radiation Sterilization Equipment
      • 8.1.1.4. Disinfection Equipment
        • 8.1.1.4.1. Disinfector
          • 8.1.1.4.1.1. Disinfector
            • 8.1.1.4.1.1.1. Washer Disinfector
            • 8.1.1.4.1.1.2. Flusher Disinfector
        • 8.1.1.4.2. Flusher Disinfector
      • 8.1.1.5. Endoscopic Reprocessor Systems
        • 8.1.1.5.1. Single Basin Endoscopic Reprocessor Systems
        • 8.1.1.5.2. Dual Basin Endoscopic Reprocessor Systems
      • 8.1.1.6. Disinfectants
  • 8.2. Middle East & Africa Hospital Acquired Infection Control Market Outlook, by End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Hospitals
      • 8.2.1.2. Ambulatory Surgical Centres
      • 8.2.1.3. Medical Institutions
      • 8.2.1.4. Diagnostic Laboratories
      • 8.2.1.5. Clinics
  • 8.3. Middle East & Africa Hospital Acquired Infection Control Market Outlook, by Country, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. GCC Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.3.1.2. GCC Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.3.1.3. South Africa Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.3.1.4. South Africa Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.3.1.5. Egypt Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.3.1.6. Egypt Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.3.1.7. Nigeria Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.3.1.8. Nigeria Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.3.1.9. Rest of Middle East & Africa Hospital Acquired Infection Control Market by Product, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
      • 8.3.1.10. Rest of Middle East & Africa Hospital Acquired Infection Control Market End User, Value (US$ Bn) and Volume (Million Units), 2018 - 2031
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Product vs End User Heatmap
  • 9.2. Manufacturer vs End User Heatmap
  • 9.3. Company Market Share Analysis, 2023
  • 9.4. Competitive Dashboard
  • 9.5. Company Profiles
    • 9.5.1. Olympus Corporation
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Product Portfolio
      • 9.5.1.3. Financial Overview
      • 9.5.1.4. Business Strategies and Development
    • 9.5.2. Medivators Inc. (Cantel Medical Corp.)
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Product Portfolio
      • 9.5.2.3. Financial Overview
      • 9.5.2.4. Business Strategies and Development
    • 9.5.3. Getinge Group
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Product Portfolio
      • 9.5.3.3. Financial Overview
      • 9.5.3.4. Business Strategies and Development
    • 9.5.4. STERIS Plc.
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Product Portfolio
      • 9.5.4.3. Financial Overview
      • 9.5.4.4. Business Strategies and Development
    • 9.5.5. Belimed AG (Metall Zug)
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Product Portfolio
      • 9.5.5.3. Financial Overview
      • 9.5.5.4. Business Strategies and Development
    • 9.5.6. Steelco S.P.A.
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Product Portfolio
      • 9.5.6.3. Financial Overview
      • 9.5.6.4. Business Strategies and Development
    • 9.5.7. Pfizer Inc.,
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Product Portfolio
      • 9.5.7.3. Financial Overview
      • 9.5.7.4. Business Strategies and Development
    • 9.5.8. F. Hoffmann-La Roche Ltd,
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Product Portfolio
      • 9.5.8.3. Financial Overview
      • 9.5.8.4. Business Strategies and Development
    • 9.5.9. Merck & Co.,
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Product Portfolio
      • 9.5.9.3. Financial Overview
      • 9.5.9.4. Business Strategies and Development
    • 9.5.10. Advanced Sterilization Products Services Inc. (Johnson & Johnson)
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Product Portfolio
      • 9.5.10.3. Financial Overview
      • 9.5.10.4. Business Strategies and Development
    • 9.5.11. Abbott Laboratories
      • 9.5.11.1. Company Overview
      • 9.5.11.2. Product Portfolio
      • 9.5.11.3. Financial Overview
      • 9.5.11.4. Business Strategies and Development
    • 9.5.12. Bayer AG
      • 9.5.12.1. Company Overview
      • 9.5.12.2. Product Portfolio
      • 9.5.12.3. Financial Overview
      • 9.5.12.4. Business Strategies and Development
    • 9.5.13. The 3M Company
      • 9.5.13.1. Company Overview
      • 9.5.13.2. Product Portfolio
      • 9.5.13.3. Financial Overview
      • 9.5.13.4. Business Strategies and Development
    • 9.5.14. Cepheid Inc.
      • 9.5.14.1. Company Overview
      • 9.5.14.2. Product Portfolio
      • 9.5.14.3. Financial Overview
      • 9.5.14.4. Business Strategies and Development
    • 9.5.15. UVision360 Inc.
      • 9.5.15.1. Company Overview
      • 9.5.15.2. Product Portfolio
      • 9.5.15.3. Financial Overview
      • 9.5.15.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations